A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
Melissa A. Geller(University of Minnesota), Sarah Cooley(University of Minnesota), Patricia L. Judson(University of Minnesota), Rahel Ghebre(University of Minnesota), Linda F. Carson(University of Minnesota), Peter A. Argenta(University of Minnesota), Amy L. Jonson(University of Minnesota), Angela Panoskaltsis‐Mortari(University of Minnesota), Julie Curtsinger(Masonic Cancer Center), David H. McKenna(University of Minnesota), Kathryn E. Dusenbery(University of Minnesota), Robin Bliss(University of Minnesota), Levi S. Downs(University of Minnesota), Jeffrey S. Miller(University of Minnesota)
Cited by 428
Abstract
Related Papers
No related papers found
Powered by citation graph analysis